eden semaglutide GLP‑1 Review 2026: Flat‑Fee Ozempic, Wegovy & Compounded Explained eden semaglutide price Eden GLP-1

At week 12, patients receiving GS-0976 experienced a 43% median relative decrease in liver fat content, from 15.7 to 9.0% ( p = 0.006), as measured by magnetic resonance imaging-proton density fat fraction (MRI-PDFF)

For reference, tirzepatide, the clinical name for Zepbound and Mounjaro, led patients to lose 20.2% of their weight at 72 weeks

By synergistically influencing all three, Retatrutide appears to create a powerful metabolic shift that supports rapid and sustained fat loss

The mechanism is sound and the early data is strong

By May 2025, prescribing reached 1.2% of all prescriptions, nearly double AOM semaglutides prescribing rates